Molecular aspects of myocarditis

Current Opinion in Cardiology

Volumn 13, Issue 3, 1998, Pages 179-184

  Bowles, Neil E ^a   Towbin, Jeffrey A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL MODEL; APOPTOSIS; AUTOIMMUNITY; COXSACKIE VIRUS B; ENDOCARDIAL FIBROELASTOSIS; HEART MUSCLE; HUMAN; INCIDENCE; MOUSE; MUMPS; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VACCINATION; VIRUS INFECTION;

ADULT; ANIMALS; APOPTOSIS; CARDIOMYOPATHY, DILATED; CHILD; CYTOKINES; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; MYOCARDITIS; VIRAL VACCINES; VIRUS DISEASES;

EID: 0031778992     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Sole MJ, Lui P: Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol 1993, 22(suppl A):99A-105A.
2. O'Connell JB, Brislow MR: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994, 13(suppl):S107-S112.
3. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC: Detection of coxsackie-B-virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986, 1:1120-1122.
4. Kandolf R, Ameis D, Kirschner P, Canu A, Hofschnieder PH: In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A 1987, 84:6272-6276.
5. Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearney D, Zhang Y-H, Bodurtha J, Gelb B, Ni J, Bricker T, Towbin JA: Acute myocarditis: rapid diagnosis by PCR in children. Circulation 1994, 90:330-333.
6. Towbin JA, Griffin LD, Martin AB, Nelson S, Su B, Ayres NA, Demmler G, Moise KJ, Zhang Y-H: Intrauterine adenoviral myocarditis presenting as nonimmune hydrops fetalis: diagnosis by polymerase chain reaction. Pediatr Infect Dis J 1994, 13:144-150.
7. Griffin LD, Kearney D, Ni J, Jaffe R, Fricker FJ, Webber S, Demmler G, Gelb BD, Towbin JA: Analysis of formalin-fixed and frozen myocardial autopsy samples for viral genome in childhood myocarditis and dilated cardiomyopathy with endocardial fibroelastosis using polymerase chain reaction (PCR). Cardiovasc Pathol 1995, 4:3-11.
8. Schonian U, Crombach M, Maser S, Maisch B: Cytomegalovirus-associated heart muscle disease. Eur Heart J 1995, 16(suppl O):46-49
9. Bowles NE, Towbin JA: Viral heart muscle disease in children. Newsletter of the Scientific Council for Cardiomyopathies 1996, 11:4-5.
10. Matsumori A: Molecular and immune mechanisms in the pathogenesis of cardiomyopathy: role of viruses, cytokines and nitric oxide. Jpn Circ J 1997, 61:275-291. This is a well-written update of the field of myocarditis, particularly with reference to the role of cytokines and hepatitis C virus.
11. Tu Z, Chapman NM, Hufnagel G, Tracy S, Romero JR, Barry WH, Zhao L, Currey K, Shapiro B: The cardiovirulent phenotype of coxsackievirus 63 is determined at a single site in the genomic 5′ nontranslated region. J Virol 1995, 69:4607-4618.
12. Chapman NM, Romero JR, Pallansch MA, Tracy S: Sites other than nucleotide 234 determine cardiovirulence in natural isolated of coxsackievirus B3. J Med Virol 1997, 52:258-261.
13. Lee C, Maull E, Chapman N, Tracy S, Gauntt C: Genomic regions of coxsacklevirus B3 associated with cardiovirulence. J Med Virol 1997, 52:341-347.
14. Cunningham L, Bowles NE, Lane RJM, Dubowitz V, Archard LC: Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol 1990, 71:1399-1402.
15. Andreoletti L, Hober D, Becquart P, Belaich S, Copin MC, Lambert V, Wattre P: Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection. J Med Virol 1997, 52:206-214.
16. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithvas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW: Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323. The isolation of a cDNA clone that encodes the common receptor for the coxsackievirus B and adenovirus (subgroup C) families is described. The expression of this protein is capable of permitting the attachment and entry of these viruses into nonpermissive cell lines.
17. Tomko RP, Xu R, Philipson L: HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 1997, 94:3352-3356. This article characterizes the common receptor for the coxsackievirus B and adenovirus (subgroup C) families from both human and mouse cells. These 46-kD glycoproteins share significant homology and are part of the immunoglobulin-like receptor superfamily, having a transmembrane and two extracellular domains.
18. Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
19. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994, 72:561-566.
20. Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM: Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis. J Card Fail 1997, 3:117-124. The cardiac-specific expression of tumor necrosis factor-α (TNF-α) under the control of the α-myosin heavy-chain promoter in transgenic mice results in animals with grossly enlarged hearts and severe inflammatory infiltrates. This model is highly reminiscent of acute human myocarditis and provides considerable evidence that TNF-α plays an important role in the development of pathology.
21. Satoh M, Tamaura G, Segawa I, Tashiro A, Hiramori K, Satodate R: Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch 1996, 427:503-509. Using reverse transcription polymerase chain reaction, the continued expression of tumor necrosis factor-α and interleukin-8 were shown to occur in a number of patients who progressed from myocarditis to dilated cardiomyopathy, together with persistent infection of the myocardium by enteroviruses.
22. Shoi T, Matsumori A, Nishio R, Ono K, Kakio T, Sasayama S: Protective role of interleukin-12 in viral myocarditis. J Mol Cell Cardiol 1997, 29:2327-2334.
23. Shioi T, Matsumori A, Sasayama S: Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 1996, 94:2930-2937.
24. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF: Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischemic or valvar heart disease. Br Heart J 1995, 74:426-430.
25. Mikami S, Kawashima S, Kanazawa K, Hirata K, Katayama Y, Hotta H, Hayashi Y, Ito H, Yokoyama M: Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem Biophys Res Comm 1996, 220:983-989.
26. Bachmaier K, Neu N, Pummerer C, Duncan GS, Mak TW, Matsuyama T, Penninger JM: iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997, 96:585-591. Inducible nitric oxide synthase (iNOS) is up-regulated in this autoimmune model of myocarditis in mice. iNOS induction is not essential for the development of myocarditis in this model because mice lacking interferon regulatory transcription factor 1, which controls iNOS induction, showed no difference in the seventy of pathology by comparison with control animals after induction of disease.
27. Ishiyama S, Hiroe M, Nishikawa T, Abe S, Shimojo T, Ito H, Ozasa S, Yamakawa K, Matsuzaki M, Uddin Mohammed M, Nakazawa H, Kasajima T, Marumo F: Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997, 95:489-496. In an autoimmune rat model of myocarditis, the administration of aminoguanidine (which inhibits inducible nitric oxide synthase [iNOS] expression) reduced the severity of inflammation in the myocardium, suggesting an important role for nitric oxide synthesis in disease pathology. This article and the previous article [26•] provide contradictory information for the importance of iNOS induction in autoimmune myocarditis
28. Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson CB, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T: Characterization of the cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 1997, 29:491-502.
29. Cohen JJ: Apoptosis. Immunol Today 1993, 14:126-130.
30. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A: Apoptosis in myocytes in end-stage heart disease. N Engl J Med 1996, 335:1182-1189. This is the first demonstration of increased numbers of apoptotic cardiomyocytes in the myocardium of patients with idiopathic dilated cardiomyopathy, suggesting a novel mechanism of pathology in these patients.
31. Bowles NE, Kearney D, Ni J, Towbin JA: Association of adenovirus infection with apoptosis in the pathogenesis of myocarditis and dilated cardiomyopathy. Pediatr Res 1997, 41:19a. This article demonstrates increased numbers of cells (cardiomyocytes and inflammatory cells) undergoing apoptosis in myocardial sections from patients with myocarditis or dilated cardiomyopathy associated with adenovirus infection.
32. Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat Med 1996, 2:1361-1366.
33. White E: Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc Soc Exp Biol Med 1993, 204:30-39.
34. Woodruff JF: Viral myocarditis: a review. Am J Pathol 1980, 101:425-466.
35. Huber SA: Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab Invest 1997, 76:691-701. The effects of genetic background on the response to coxsackievirus B infection in mice are further characterized, including characterization of the inflammatory response, the induction of apoptosis, and the correlation of serum atrial natriuretic factor with severity of pathology and the activation of CD8+ lymphocytes.
36. Schultheiss H-P, Schulze K, Kuhl U, Ulrich G, Klingenberg M: The ADP/ATP carrier as an mitochondrial autoantigen: facts and perspectives. Ann N Y Acad Sci 1987, 488:44-64.
37. Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S: Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992, 85:1734-1742.
38. Schwimmbeck PL, Schultheiss H-P, Strauer BE: Identification of a main autoimmunogenic epitope of the adenine nucleotide translocator which cross reacts with Coxsackie B3 virus: use in the diagnosis of myocarditis and dilated cardiomyopathy. Circulation 1989, 80(suppl 11:665.
39. Schultheiss H-P, Schulze K, Dorner A: Significance of the adenine nucleotide translocator in the pathogenesis of viral heart disease. Mol Cell Biochem 1996, 163/164:319-327. This article offers a comprehensive description of changes in the amount and function of the adenine translocator protein in myocarditis and dilated cardiomyopathy patients. In animal models, the stimulation of autoantibodies against this protein led to decreased cardiac function associated with reduced mitochondnal transport and altered energy metabolism.
40. Pankuweit S, Portig I, Lottspeich F, Maisch B: Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 1997, 29:77-84.
41. Zhang HY, Morgan-Capner P, Latif N, Pandolfino YA, Fan W, Dunn MJ, Archard LC: Coxsackievirus B3-induced myocarditis: characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain. Am J Pathol 1997, 150:2197-2207. The description of an attenuated coxsackievirus B3 strain that failed to infect the heart or induce autoantibody formation in mice and subsequently protected the mice against challenge with a cardiovirulent virus strain.
42. Ni J, Bowles NE, Kim Y-H, Demmler G, Kearney D, Bricker JT, Towbin JA: Viral infection of the myocardium in endocardial fibroelastosis: molecular evidence for the role of mumps virus as an etlological agent. Circulation 1997, 95:133-139. Proof of the role of mumps virus infection of the myocardium in patients with endocardial fibroelastosis is provided. This confirms the hypothesis that the introduction of the mumps virus vaccine was responsible for the almost complete elimination of this disease, with the remaining cases being due to adenovirus in the most part. These studies reinforce the notion that vaccination could potentially be important in reducing the frequency of myocarditis and dilated cardiomyopathy.
43. Gaydos CA: Adenovirus vaccines in the US military. Milit Med 1995, 160:300-304.